Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.12.20	Sanofi: CHMP Adopts Positive Opinion For Additional Indication For Plavix (RTTNews)
11.12.20	Sanofi, GSK Delay COVID-19 Vaccine Program Due To Low Immune Response In Elderly People (RTTNews)
09.12.20	Sanofi, Kiadis Satisfy Competition Condition Regarding Tender Offer (RTTNews)
30.11.20	Sanofi, Kiadis Issue Update On Public Offer - Quick Facts (RTTNews)
30.11.20	Regeneron Reports Approval Of Dupixent In Europe For Children With Severe Atopic Dermatitis (RTTNews)
19.11.20	Sanofi: European Commission Approves Supemtek Recombinant Influenza Vaccine (RTTNews)
18.11.20	Sanofi: Rilzabrutinib Granted Fast Track Designation - Quick Facts (RTTNews)
18.11.20	Sanofi: FDA Grants Priority Review For Avalglucosidase Alfa - Quick Facts (RTTNews)
14.11.20	FDA Issues CRL For Sanofi's Sutimlimab Due To Deficiencies In Third-party Manufacturing Facility (RTTNews)
08.11.20	Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing (RTTNews)
02.11.20	Sanofi Offers To Buy Dutch NK Cell Therapy Developer Kiadis For EUR 5.45/share (RTTNews)
30.10.20	Regeneron : IDMC Recommends To Hold Enrollment In Hospitalized High Risk COVID-19 Patients (RTTNews)
29.10.20	European Patent Office Rules In Favor Of Sanofi, Regeneron On Praluent (RTTNews)
29.10.20	Sanofi Q3 Business Net Income Rises; Increases 2020 Business EPS Guidance (RTTNews)
28.10.20	Sanofi, GSK Intend To Supply 200 Mln Doses Of COVID-19 Vaccine To COVAX Facility (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
16.10.20	SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
13.10.20	Regeneron: Phase 3 Trial Shows Dupixent Significantly Reduces Severe Asthma Attacks In Children (RTTNews)
02.10.20	Europe Accepts Sanofi's Regulatory Submission For Enzyme Replacement Therapy For Pompe Disease (RTTNews)
22.09.20	Sanofi - Principia Biopharma Deal Receives U.S. Antitrust Approval (RTTNews)
18.09.20	Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
14.09.20	Regeneron And Sanofi: Dupixent Granted FDA Breakthrough Therapy Designation For EoE (RTTNews)
08.09.20	Regeneron/Sanofi Reveal Promising Long-term Data Of Dupixent In Moderate-to-severe Asthma (RTTNews)
03.09.20	Sanofi, GSK Begin Phase 1/2 Clinical Trial For Adjuvanted COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
02.09.20	ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again (RTTNews)
01.09.20	Sanofi Says Kevzara Trial Failed To Meet Endpoints In COVID-19 Patients Outside U.S. (RTTNews)
28.08.20	Sanofi To Commence Tender Offer To Acquire Principia Biopharma (RTTNews)
18.08.20	NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr. (RTTNews)
17.08.20	Sanofi Agrees To Buy Principia Biopharma In $3.68 Bln Deal - Quick Facts (RTTNews)
12.08.20	U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine (RTTNews)
11.08.20	Perrigo To Acquire Three Eastern European OTC Self-Care Brands From Sanofi - Quick Facts (RTTNews)
03.08.20	Sanofi, GSK In Talks To Supply EU With Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
31.07.20	Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government's Operation Warp Speed (RTTNews)
29.07.20	Sanofi, GSK In Deal With UK Government To Supply Up To 60 Mln Doses Of COVID-19 Vaccine (RTTNews)
17.07.20	Sanofi Reportedly Considers Acquisitions Of U.S. Biotechnology Companies (RTTNews)
09.07.20	Kymera Partners With Sanofi To Advance Novel Protein Degrader Therapies (RTTNews)
08.07.20	Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs To Sanofi - Quick Facts (RTTNews)
03.07.20	Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals (RTTNews)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
26.06.20	Sanofi Plans To Cut 1,700 Jobs In Europe (RTTNews)
24.06.20	Translate Bio (TBIO) Delivers 175% Gain In Little Less Than 3 Months (RTTNews)
24.06.20	INO Hits New High, APYX Expands Footprint, TBIO/SNY To Begin COVID-19 Vaccine Trial In Q4 (RTTNews)
23.06.20	Sanofi, Translate Bio Expand Collaboration To Develop MRNA Vaccines For Infectious Diseases (RTTNews)
19.06.20	Regeneron : China Okays Dupixent To Treat Moderate-to-Severe Atopic Dermatitis In Adults (RTTNews)
16.06.20	Sanofi: Avalglucosidase Phase 3 Trial Shows Clinically Meaningful Improvement (RTTNews)
16.06.20	Sanofi To Create Production Site, Research Center In France Dedicated To Vaccines (RTTNews)
15.06.20	Sanofi, Sobi Donate Up To 500 Mln Addl IUs Of Clotting Factor To WFH Humanitarian Aid Program (RTTNews)
11.06.20	Sanofi To Present Strategy For Dupixent In Type 2 Inflammatory Diseases (RTTNews)
09.06.20	Alphamab Oncology, Sanofi Collaborate On KN026 In HER2+ Breast Cancer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

20.12.24		Wechsel bei Sanofi: Ex-Morphosys-Chef Kress tritt in den Verwaltungsrat ein -Sanofi-Aktie tiefer
17.10.24		Sanofi-Aktie wenig bewegt: Sorgen der Regierung gegen Opella-Teilverkauf sollen beschwichtigt werden
04.10.24		Sanofi-Aktie gefragt: Recordati erwirbt Sanofi Enjaymo-Rechte für eine knappe Milliarde Dollar
12.09.24		Sanofi startet Kooperation zur Bekämpfung seltener Krebserkrankungen - Aktie gibt nach
11.09.24		Sanofi mit Studienerfolg: Dupixent hilft bei Hautkrankheiten - Aktie dennoch tiefer
02.09.24		Sanofi-Medikament Tolebrutinib zeigt gute Ergebnisse - Sanofi-Aktionäre begeistert
04.07.24		Sanofi-Aktie kaum bewegt: Bain und Cinven ziehen wohl Übernahme von Sanofis Consumer-Sparte in Betracht
03.07.24		Sanofi-Aktie moderat im Plus: Dupixent von Sanofi erhält EU-Zulassung für COPD-Behandlung

20.12.24

Wechsel bei Sanofi: Ex-Morphosys-Chef Kress tritt in den Verwaltungsrat ein -Sanofi-Aktie tiefer

17.10.24

Sanofi-Aktie wenig bewegt: Sorgen der Regierung gegen Opella-Teilverkauf sollen beschwichtigt werden

04.10.24

Sanofi-Aktie gefragt: Recordati erwirbt Sanofi Enjaymo-Rechte für eine knappe Milliarde Dollar

12.09.24

Sanofi startet Kooperation zur Bekämpfung seltener Krebserkrankungen - Aktie gibt nach

11.09.24

Sanofi mit Studienerfolg: Dupixent hilft bei Hautkrankheiten - Aktie dennoch tiefer

02.09.24

Sanofi-Medikament Tolebrutinib zeigt gute Ergebnisse - Sanofi-Aktionäre begeistert